Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose
Alessandra Mangia(Casa Sollievo della Sofferenza), Valeria Piazzolla(Casa Sollievo della Sofferenza), Paolo Cantaloni(VisMederi Research), Giovanna Cocomazzi(Casa Sollievo della Sofferenza), Alessandro Manenti(VisMederi Research), Emanuele Montomoli(University of Siena), Francesco Giuliani(University of Campania "Luigi Vanvitelli"), Vincenzo Giambra(Casa Sollievo della Sofferenza), Stefano Antinucci(Casa Sollievo della Sofferenza), Alberto Maiorana(Casa Sollievo della Sofferenza), Nicola Serra(Unknown)
Cited by 16
Related Papers
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Neo-adjuvant and adjuvant chemotherapy of gastric cancer
|Annals of Oncology|2007|63
The Impact of the Female Genital Microbiota on the Outcome of Assisted Reproduction Treatments
|Microorganisms|2023|46
Hepatitis C virus micro-elimination: Where do we stand?
|World Journal of Gastroenterology|2021|26
Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy
|International Journal of Molecular Sciences|2024|23